The Cancer Immunotherapy Congress 2016 is dedicated to Cancer Immunotherapy challenges and developments.
Topics
- Predictive Biomarkers for response
- Cellular Immunotherapy
- New Immunotherapy Targets
- Combinational Therapy and Toxicity
- Moving Beyond Current Vaccines
- Pre-clinical & Translational
Who should Attend
Scientists, academicians and professionals from:
- Bio-technology companies
- Pharmaceutical and Bio-pharmaceutical companies
- Research institutes
